What are the major opportunities in the Isocitrate Dehydrogenase IDH Inhibitors market? What are the strategies for the Isocitrate Dehydrogenase IDH Inhibitors market?

For detailed insights on the major opportunities and strategies in the Isocitrate Dehydrogenase IDH Inhibitors market, Read More

How does the Isocitrate Dehydrogenase IDH Inhibitors market relate to the overall economy and other similar markets?

For detailed insights on Isocitrate Dehydrogenase IDH Inhibitors's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Isocitrate Dehydrogenase IDH Inhibitors market growth? SWOT analysis of the Isocitrate Dehydrogenase IDH Inhibitors market.

For detailed insights on the key dynamics influencing the Isocitrate Dehydrogenase IDH Inhibitors market growth and SWOT analysis of the Isocitrate Dehydrogenase IDH Inhibitors industry, Read More

Isocitrate Dehydrogenase (IDH) Inhibitors Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Isocitrate Dehydrogenase (IDH) Inhibitors Market Report 2026

Name: Isocitrate Dehydrogenase (IDH) Inhibitors Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor, Other Types), By Molecule Type (Monoclonal Antibodies, Peptides, Small Molecules, Other Molecule Types), By Route Of Administration (Oral, Parenteral, Subcutaneous, Topical), By Application (FLT3 Inhibitor, DH Inhibitor, Hedgehog Pathway Inhibitor, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

• Isocitrate Dehydrogenase (IDH) Inhibitors market size has reached to $2.46 billion in 2025

• Expected to grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 26.6%

• Growth Driver: Increase In Acute Myeloid Leukemia Driving Growth Of The Market Due To Rising Incidence Among Aging And At-Risk Populations

• Market Trend: FDA Approves First Targeted Therapy For Grade 2 IDH-Mutant Glioma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Isocitrate Dehydrogenase (IDH) Inhibitors Market?

Isocitrate Dehydrogenase (IDH) Inhibitors are a class of targeted cancer therapies designed to block the activity of mutated forms of the IDH1 and IDH2 enzymes. These enzymes are involved in cellular metabolism, and gene mutations can lead to abnormal cell growth and cancer development.

The main types of isocitrate dehydrogenase (IDH) inhibitors are IDH1 mutant medullary malignant tumor, IDH2 mutant medullary malignant tumor, and others. IDH1 mutant medullary malignant tumor refers to a type of cancerous growth that originates in the medullary (central) part of an organ or tissue and is characterized by a mutation in the IDH1 gene. It includes molecule types, such as monoclonal antibodies, peptides, small molecules, and others, and is administered through oral, parenteral, subcutaneous, and topical routes. It is used for applications such as FLT3 inhibitors, DH inhibitors, hedgehog pathway inhibitors, and others.

Isocitrate Dehydrogenase (IDH) Inhibitors Market Global Report 2026 Market Report bar graph

What Is The Isocitrate Dehydrogenase (IDH) Inhibitors Market Size and Share 2026?

The isocitrate dehydrogenase (idh) inhibitors market size has grown exponentially in recent years. It will grow from $2.46 billion in 2025 to $3.13 billion in 2026 at a compound annual growth rate (CAGR) of 26.8%. The growth in the historic period can be attributed to cancer genomics research, unmet oncology needs, mutation-driven drug discovery, hospital oncology adoption, clinical trial expansion.

What Is The Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Forecast?

The isocitrate dehydrogenase (idh) inhibitors market size is expected to see exponential growth in the next few years. It will grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 26.6%. The growth in the forecast period can be attributed to precision medicine advancement, biomarker-driven oncology care, rare cancer drug pipelines, combination cancer therapies, regulatory support for targeted drugs. Major trends in the forecast period include expansion of targeted oncology therapies, increased genetic mutation-based drug development, growing focus on rare cancer treatment, rising use of precision oncology diagnostics, advancement of small molecule cancer inhibitors.

Book your 30 minutes free consultation with our research experts

Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Segmentation

1) By Type: IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor, Other Types

2) By Molecule Type: Monoclonal Antibodies, Peptides, Small Molecules, Other Molecule Types

3) By Route Of Administration: Oral, Parenteral, Subcutaneous, Topical

4) By Application: FLT3 Inhibitor, DH Inhibitor, Hedgehog Pathway Inhibitor, Other Applications

Subsegments:

1) By IDH1 Mutant Medullary Malignant Tumor: Acute Myeloid Leukemia (AML), Glioma Or Glioblastoma, Cholangiocarcinoma, Chondrosarcoma

2) By IDH2 Mutant Medullary Malignant Tumor: Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Angioimmunoblastic T-Cell Lymphoma (AITL)

3) By Other Types: Solid Tumors With IDH Mutations, Metastatic Cancers With IDH Alterations, Experimental Or Off-Label Uses In Rare Cancers

What Is The Driver Of The Isocitrate Dehydrogenase (IDH) Inhibitors Market?

The increase in the frequency of acute myeloid leukemia is expected to propel the growth of the isocitrate dehydrogenase (IDH) inhibitors market going forward. Acute myeloid leukemia (AML) refers to a fast-growing cancer of the blood and bone marrow characterized by the rapid production of abnormal white blood cells that interfere with normal blood cell formation. The increase in the incidence of acute myeloid leukemia is due to the rise in the aging population as older adults face a higher risk of developing this aggressive blood cancer due to age-related changes in their bone marrow and immune system. Isocitrate dehydrogenase (IDH) inhibitors help treat acute myeloid leukemia by blocking mutant IDH enzymes, which restores normal blood cell development and slow the growth of leukemia cells. For instance, in February 2023, according to the report published by Leukaemia Foundation, an Australia-based non-profit organization, from 2022 to 2035, more than 7,000 children, 6,000 young adults, and 108,000 adults aged 25–65 are expected to be diagnosed with blood cancers, primarily acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin lymphoma (NHL). Therefore, an increase in the frequency of acute myeloid leukemia is expected to propel the growth of the isocitrate dehydrogenase (IDH) inhibitors industry.

Key Players In The Global Isocitrate Dehydrogenase (IDH) Inhibitors Market

Major companies operating in the isocitrate dehydrogenase (idh) inhibitors market are Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Daiichi Sankyo Company Limited, Les Laboratoires Servier, Evotec SE, HUTCHMED (China) Limited, Rigel Pharmaceuticals Inc., CStone Pharmaceuticals, Forma Therapeutics Holdings Inc., Philogen S.p.A., Kura Oncology Inc., Agios Pharmaceuticals Inc., Adooq Bioscience LLC, Taiho Pharmaceutical Co. Ltd., Celgene Corporation, Focus Biomolecules LLC, InvivoChem LLC

Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Trends and Insights

Major companies operating in the isocitrate dehydrogenase (IDH) inhibitors market are focusing on obtaining regulatory approvals to expand the clinical use of their therapies, accelerate market entry, and gain a competitive advantage in treating IDH-mutant cancers. Regulatory approvals refer to official permissions granted by health authorities that allow a drug to be marketed and used after confirming its safety and effectiveness. For instance, in August 2024, Servier Laboratoires, a France-based pharmaceutical company, received FDA approval for VORANIGO (vorasidenib) tablets as the first targeted therapy for patients with Grade 2 IDH-mutant glioma, including astrocytoma and oligodendroglioma with IDH1 or IDH2 mutations. This oral treatment significantly improves progression-free survival, as shown in the Phase 3 INDIGO trial, where patients had a median progression-free survival of 27.7 months versus 11.1 months for placebo. VORANIGO offers a convenient and well-tolerated option with manageable side effects, marking a significant advancement for a patient group with limited prior treatment choices.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Isocitrate Dehydrogenase (IDH) Inhibitors Market?

In November 2025, Amoy Diagnostics Co. Ltd., a China-based healthcare technology company, partnered with Servier, to expand precision oncology and genetic testing solutions. With this partnership, Amoy Diagnostics and Servier aim to enhance cancer and rare disease diagnostics by combining Amoy’s molecular diagnostic assays with Servier’s clinical genomics and therapeutic expertise to provide faster, more accurate, and widely accessible testing, while improving data interpretation, streamlining laboratory workflows, and enabling broader patient access to personalized medicine. Servier is a France-based healthcare technology company that specializes in developing and commercializing innovative therapeutics and diagnostic solutions across oncology, cardiology, and rare diseases.

Regional Insights

North America was the largest region in the isocitrate dehydrogenase (IDH) inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Isocitrate Dehydrogenase (IDH) Inhibitors Market?

The isocitrate dehydrogenase (IDH) inhibitors market consists of sales of selective IDH1 inhibitors, selective IDH2 inhibitors, dual IDH1/IDH2 inhibitors, combination therapies, and delivery forms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods, such as formulation development, packaging, and regulatory support.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Isocitrate Dehydrogenase (IDH) Inhibitors Market Report 2026?

The isocitrate dehydrogenase (idh) inhibitors market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the isocitrate dehydrogenase (idh) inhibitors industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Isocitrate Dehydrogenase (IDH) Inhibitors Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$3.13 billion
Revenue Forecast In 2035	$8.02 billion
Growth Rate	CAGR of 26.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Molecule Type, Route Of Administration, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Daiichi Sankyo Company Limited, Les Laboratoires Servier, Evotec SE, HUTCHMED (China) Limited, Rigel Pharmaceuticals Inc., CStone P
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Isocitrate Dehydrogenase (IDH) Inhibitors Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Isocitrate Dehydrogenase (IDH) Inhibitors Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Targeted Oncology Therapies

4.2.2 Increased Genetic Mutation-Based Drug Development

4.2.3 Growing Focus On Rare Cancer Treatment

4.2.4 Rising Use Of Precision Oncology Diagnostics

4.2.5 Advancement Of Small Molecule Cancer Inhibitors

5. Isocitrate Dehydrogenase (IDH) Inhibitors Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Cancer Research Centers

5.4 Specialty Clinics

5.5 Academic Medical Centers

6. Isocitrate Dehydrogenase (IDH) Inhibitors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Isocitrate Dehydrogenase (IDH) Inhibitors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size, Comparisons And Growth Rate Analysis

7.3. Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Isocitrate Dehydrogenase (IDH) Inhibitors Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Isocitrate Dehydrogenase (IDH) Inhibitors Market Segmentation

9.1. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

IDH1 Mutant Medullary Malignant Tumor, IDH2 Mutant Medullary Malignant Tumor, Other Types

9.2. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Peptides, Small Molecules, Other Molecule Types

9.3. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Subcutaneous, Topical

9.4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

FLT3 Inhibitor, DH Inhibitor, Hedgehog Pathway Inhibitor, Other Applications

9.5. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH1 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Myeloid Leukemia (AML), Glioma Or Glioblastoma, Cholangiocarcinoma, Chondrosarcoma

9.6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH2 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Angioimmunoblastic T-Cell Lymphoma (AITL)

9.7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Solid Tumors With IDH Mutations, Metastatic Cancers With IDH Alterations, Experimental Or Off-Label Uses In Rare Cancers

10. Isocitrate Dehydrogenase (IDH) Inhibitors Market Regional And Country Analysis

10.1. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market

11.1. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Isocitrate Dehydrogenase (IDH) Inhibitors Market

12.1. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Isocitrate Dehydrogenase (IDH) Inhibitors Market

13.1. India Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market

14.1. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

14.2. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market

15.1. Australia Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Isocitrate Dehydrogenase (IDH) Inhibitors Market

16.1. Indonesia Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market

17.1. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

17.2. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Isocitrate Dehydrogenase (IDH) Inhibitors Market

18.1. Taiwan Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

18.2. Taiwan Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market

19.1. South East Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

19.2. South East Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market

20.1. Western Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

20.2. Western Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market

21.1. UK Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market

22.1. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Isocitrate Dehydrogenase (IDH) Inhibitors Market

23.1. France Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market

24.1. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Isocitrate Dehydrogenase (IDH) Inhibitors Market

25.1. Spain Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market

26.1. Eastern Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

26.2. Eastern Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market

27.1. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market

28.1. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

28.2. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Isocitrate Dehydrogenase (IDH) Inhibitors Market

29.1. USA Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

29.2. USA Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market

30.1. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

30.2. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Isocitrate Dehydrogenase (IDH) Inhibitors Market

31.1. South America Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

31.2. South America Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market

32.1. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Isocitrate Dehydrogenase (IDH) Inhibitors Market

33.1. Middle East Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

33.2. Middle East Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market

34.1. Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Overview

34.2. Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Segmentation By Molecule Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Isocitrate Dehydrogenase (IDH) Inhibitors Market Regulatory and Investment Landscape

36. Isocitrate Dehydrogenase (IDH) Inhibitors Market Competitive Landscape And Company Profiles

36.1. Isocitrate Dehydrogenase (IDH) Inhibitors Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Isocitrate Dehydrogenase (IDH) Inhibitors Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Isocitrate Dehydrogenase (IDH) Inhibitors Market Company Profiles

36.3.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

37. Isocitrate Dehydrogenase (IDH) Inhibitors Market Other Major And Innovative Companies

Eli Lilly and Company, Daiichi Sankyo Company Limited, Les Laboratoires Servier, Evotec SE, HUTCHMED (China) Limited, Rigel Pharmaceuticals Inc., CStone Pharmaceuticals, Forma Therapeutics Holdings Inc., Philogen S.p.A., Kura Oncology Inc., Agios Pharmaceuticals Inc., Adooq Bioscience LLC, Taiho Pharmaceutical Co. Ltd., Celgene Corporation, Focus Biomolecules LLC

38. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Isocitrate Dehydrogenase (IDH) Inhibitors Market

40. Isocitrate Dehydrogenase (IDH) Inhibitors Market High Potential Countries, Segments and Strategies

40.1 Isocitrate Dehydrogenase (IDH) Inhibitors Market In 2030 - Countries Offering Most New Opportunities

40.2 Isocitrate Dehydrogenase (IDH) Inhibitors Market In 2030 - Segments Offering Most New Opportunities

40.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Overview Of Key Products - Product Examples

Table 2: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Supply Chain Analysis

Table 4: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Raw Material Providers

Table 5: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Resource Providers

Table 6: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Manufacturers (Suppliers)

Table 7: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Distributors And Channel Partners

Table 8: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Key Technologies & Future Trends

Table 9: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Trends

Table 10: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major End Users

Table 11: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market - TAM, US$ Billion, 2025

Table 15: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH1 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH2 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Isocitrate Dehydrogenase (IDH) Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market - Company Scoring Matrix

Table 98: Roche Holding AG Financial Performance

Table 99: Merck & Co. Inc. Financial Performance

Table 100: Bristol-Myers Squibb Company Financial Performance

Table 101: Novartis AG Financial Performance

Table 102: GlaxoSmithKline plc Financial Performance

Table 103: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Competitive Dashboard

Table 105: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 107: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

Table 108: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Overview Of Key Products - Product Examples

Figure 2: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Supply Chain Analysis

Figure 4: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Raw Material Providers

Figure 5: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Resource Providers

Figure 6: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Manufacturers (Suppliers)

Figure 7: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Distributors And Channel Partners

Figure 8: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Key Technologies & Future Trends

Figure 9: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major Trends

Figure 10: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Major End Users

Figure 11: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market - TAM, US$ Billion, 2025

Figure 15: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH1 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of IDH2 Mutant Medullary Malignant Tumor, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Molecule Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Isocitrate Dehydrogenase (IDH) Inhibitors Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Isocitrate Dehydrogenase (IDH) Inhibitors Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market - Company Scoring Matrix

Figure 98: Roche Holding AG Financial Performance

Figure 99: Merck & Co. Inc. Financial Performance

Figure 100: Bristol-Myers Squibb Company Financial Performance

Figure 101: Novartis AG Financial Performance

Figure 102: GlaxoSmithKline plc Financial Performance

Figure 103: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market, Competitive Dashboard

Figure 105: Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 107: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Molecule Type, 2025 – 2030

Figure 108: Global, Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Proton Pump Inhibitors Market Report 2026 - Global Outlook – By Type (Pantoprazole, Omeprazole, Lansoprazole, Esomeprazole, Rabeprazole, Dexlansoprazole, Other Types), By Disease Allocation (Ulcers, Gastroesophageal Refl...

ACE Inhibitors Market Report 2026 - Global Outlook – By Type (Sulfhydryl-containing Agents, Dicarboxylate-containing Agents, Phosphonate-containing Agents), By Drug (Ramipril, Enalapril, Benazepril, Fosinopril, Captopril...

Kinase Inhibitors Market Report 2026 - Global Outlook – By Type (Tyrosine Kinase Inhibitors, Multikinase Inhibitors, mTOR Kinase Inhibitors, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By A...

Pharmacogenomics Market Report 2026 - Global Outlook – By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Other Technologies), By Application (Neurol...

Proteasome Inhibitors Market Report 2026 - Global Outlook – By Product (Velcade, Kyprolis, Ninlaro, Other Products), By Drugs (Bortezomib, Carfilzomib, Ixazomib), By Indication (Lymphoma, Mantle Cell Lymphoma, Multiple M...

Alpha Glucosidase Inhibitors Market Report 2026 - Global Outlook – By Type (Dumping Syndrome, Type 2 Diabetes), By Drug Class (Acarbose, Miglitol, Voglibose), By Constituent (Glucoamylase, Isomaltase, Maltase, Sucrase), ...

Histone Deacetylase Inhibitors Market Report 2026 - Global Outlook – By Classification (Class I Histone Deacetylases (HDACs), Class II Histone Deacetylases (HDACs), Class III Histone Deacetylases (HDACs), Other Classific...

Frequently Asked Questions

How big is the Isocitrate Dehydrogenase (IDH) Inhibitors Market?

The Isocitrate Dehydrogenase (IDH) Inhibitors market was valued at $2.46 billion in 2025, increased to $3.13 billion in 2026, and is projected to reach $8.02 billion by 2030.

What is the Isocitrate Dehydrogenase (IDH) Inhibitors market growth?

The global Isocitrate Dehydrogenase (IDH) Inhibitors market is expected to grow at a CAGR of 26.6% from 2026 to 2035 to reach $8.02 billion by 2035.

Who are the key players in Isocitrate Dehydrogenase (IDH) Inhibitors market?

Some Key Players in the Isocitrate Dehydrogenase (IDH) Inhibitors market Include, Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, Daiichi Sankyo Company Limited, Les Laboratoires Servier, Evotec SE, HUTCHMED (China) Limited, Rigel Pharmaceuticals Inc., CStone Pharmaceuticals, Forma Therapeutics Holdings Inc., Philogen S.p.A., Kura Oncology Inc., Agios Pharmaceuticals Inc., Adooq Bioscience LLC, Taiho Pharmaceutical Co. Ltd., Celgene Corporation, Focus Biomolecules LLC, InvivoChem LLC .

What is the anticipated growth trend for the Isocitrate Dehydrogenase (IDH) Inhibitors market?

Major trend in this market includes: FDA Approves First Targeted Therapy For Grade 2 IDH-Mutant Glioma. For further insights on this market. request a sample here

Which region has the most growth potential in the Isocitrate Dehydrogenase (IDH) Inhibitors market?

North America was the largest region in the isocitrate dehydrogenase (IDH) inhibitors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isocitrate dehydrogenase (idh) inhibitors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.